Priority Date: 28.02.12 (JP 20120040958)

NOVEL ANTI-HUMAN IL-23 RECEPTOR ANTIBODY

  • Application ID: EP13754932
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 4 offices
active in Legal Services and IP Portfolio Processing

Specialization

This patent has the IPC combination C07 (ORGANIC CHEMISTRY) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination C07 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 144 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 28.02.2012 - Priority Date (JP 20120040958)
  • 06.09.2013 - Publication A1 (WO2013129454)
  • 07.01.2015 - Publication A1 (EP2821416)